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Introduction 
Programmed cell death is a critical process for normal
development and tissue homeostasis (Glücksmann, 1951; Raff,
1992; Jacobson et al., 1997; Vaux and Korsmeyer, 1999).
Although the basic program of apoptosis execution remains
conserved, distinct regulatory signals have been described
depending on the cell type and developmental stage (D’Mello,
1998). Particularly interesting are the opposite actions
displayed by nerve growth factor (NGF) that can act either as
a survival factor or as a death-inducing factor (Casaccia-
Bonnefil et al., 1999; Lee et al., 2001). A coherent
understanding of the regulation of programmed cell death
during development requires a coordinated study of the
multiple signals acting on specific cells. 
Inner ear ontogenesis is an attractive model system to
analyse which signals are implicated in the modulation of cell
death and survival. The vertebrate inner ear originates from the
head ectoderm where the otic placode is formed and
invaginates to form the otic pit that later closes forming the otic
vesicle or otocyst. This is a transient embryonic structure that
undergoes a distinct period of intense cell proliferation [stages
18-22 in the chicken (Hamburger and Hamilton, 1951)]. This
proliferation precedes the differentiation of the various cell
types and compartments that will later form the adult inner ear
(Bissonnette and Fekete, 1996). In parallel, neuroblasts for the
cochleo-vestibular ganglion (CVG) migrate out from the
medial wall of the otic vesicle. The CVG contains the afferent
neurons that connect the sensory epithelium of the inner ear to
the central nervous system (Hemond and Morest, 1991).
Concomitantly with these biological processes, in the otic
primordium and CVG there are areas of intense programmed
cell death (Alvarez and Navascués, 1990; Sanz et al., 1999a).
Complementary in vivo and in vitro studies point to insulin-
like growth factor-I (IGF-I) and NGF as two key diffusible
factors operating during inner ear development (reviewed by
Torres and Giraldez, 1998; Frago et al., 2000). 
NGF and the related neurotrophins are essential for cell
survival and maintenance of the nervous system during
development (Bibel and Barde, 2000; de la Rosa and de Pablo,
2000). The role of neurotrophins in neuronal survival is mainly
mediated by the activation of high-affinity Trk receptors (Yoon
et al., 1998; Klesse and Parada, 1999). However neurotrophins
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Nerve growth factor induces cell death in organotypic
cultures of otic vesicle explants. This cell death has a
restricted pattern that reproduces the in vivo pattern of
apoptosis occurring during inner ear development. In this
study, we show that binding of nerve growth factor to its
low affinity p75 neurotrophin receptor is essential to
achieve the apoptotic response. Blockage of binding to p75
receptor neutralized nerve-growth-factor-induced cell
death, as measured by immunoassays detecting the
presence of cytosolic oligonucleosomes and by TUNEL
assay to visualize DNA fragmentation. Nerve growth factor
also induced a number of cell-death-related intracellular
events including ceramide generation, caspase activation
and poly-(ADP ribose) polymerase cleavage. Again, p75
receptor blockade completely abolished all of these effects.
Concerning the intracellular pathway, ceramide increase
depended on initiator caspases, whereas its actions
depended on both initiator and effector caspases, as shown
by using site-specific caspase inhibitors. Conversely,
insulin-like growth factor I, which promotes cell growth
and survival in the inner ear, abolished apoptosis induced
by nerve growth factor. Insulin-like growth factor
cytoprotective actions were accomplished, at least in part,
by decreasing endogenous ceramide levels and activating
Akt. Taken together, these results strongly suggest that
regulation of nerve-growth-factor-induced apoptosis in the
otocysts occurs via p75 receptor binding and is strictly
controlled by the interaction with survival signalling
pathways. 
Key words: p75 neurotrophin receptor (p75NTR), Ceramide, Caspase
activation, Cell survival, Otic vesicle, Ceramide-1-phosphate
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also bind the low-affinity p75 neurotrophin receptor (p75NTR),
which is a modulator of survival and death decisions (Casaccia-
Bonnefil et al., 1999; Barrett, 2000; Lee et al., 2001). The
p75NTR is structurally related to well known death receptors,
that is, the tumour necrosis factor- a (p55) and Fas superfamily
of receptors. Similarly, p75NTR possesses a death domain that
upon binding to ligand elicits the intracellular responses that
culminate in cell death (Beutler and van Huffel, 1994; Liepinsh
et al., 1997). p75NTR-knockout mice present severe nervous
system defects (von Schack et al., 2001). In the past few years,
the role of NGF as an inducer of apoptosis has become evident.
For example, treatment with NGF causes cell death in cultures
of mature oligodendrocytes (Casaccia-Bonnefil et al., 1996)
and in the developing chicken retina via an undefined
mechanism mediated by p75NTR (reviewed in Frade and Barde,
1998). NGF also induces apoptotic cell death in organotypic
cultures of otic vesicles (Frago et al., 1998). Interestingly,
NGF-induced cell death occurs in specific areas of the otic
vesicle and CVG, suggesting that during early inner ear
organogenesis there is strict control of NGF actions. The
presence of p75NTR has been reported at different stages of
inner ear development in several animal species, including
chicken (Hallbook et al., 1990; von Bartheld et al., 1991;
Schecterson and Bothwell, 1994; Wu and Oh, 1996). The
precise signalling pathway(s) used by p75NTR to activate cell
death remain unclear, but they may involve generation of
ceramide (Dobrowsky et al., 1994; Frago et al., 1998;
Casaccia-Bonnefil et al., 1996; Lievremont et al., 1999) and
activation of caspases-1, -2 and -3 (Gu et al., 1999) as well as
cyclin-dependent kinases (Frade, 2000).
IGF-I is a pleiotropic factor for the epithelial and neuronal
cells of the inner ear, which is where IGF-I and its type 1
receptor are expressed throughout development (León et al.,
1999). The importance of IGF-I in ear development is stressed
by the fact that deficiency in IGF-I results in sensorineural
deafness in humans (Woods et al., 1996; Woods et al., 1997).
Likewise, the lack of IGF-I in mice severely affects postnatal
survival, differentiation and maturation of the cochlear
ganglion cells and causes abnormal innervation of the sensory
cells in the organ of Corti (Camarero et al., 2001). Furthermore,
IGF-I is a survival and growth factor capable of blocking
apoptosis in organotypic cultures of chick otic vesicles (Frago
et al., 1998). By binding to its high-affinity tyrosine kinase
receptor, IGF-I activates the Raf/MAPK cascade and induces
the expression of Fos, Jun and proliferating cell nuclear antigen
(PCNA), which leads to cell growth (Frago et al., 2000; Sanz
et al., 1999b). However, little is known about the intracellular
pathways elicited by IGF-I to promote cell survival during
development. One of the pathways by which IGF-I exerts its
anti-apoptotic effect in different cell types including cells of
the nervous system is the activation of the Akt/Protein kinase
B pathway (Dudek et al., 1997). Akt family members have
been shown to be required for normal development in flies and
Caenorhabditis elegans (Paradis and Ruvkun, 1998; Verdu et
al., 1999), and Akt1-null mice present defects in both foetal
and postnatal growth (Cho et al., 2001).
Here we have explored the intracellular signalling
mechanisms elicited by NGF to induce apoptosis in the
developing inner ear and how they are balanced by survival
signals activated by IGF-I. We show that (i) p75NTR mediates
NGF pro-apoptotic effects, including ceramide generation,
caspase activation and DNA fragmentation; (ii) NGF induces
ceramide generation via synthesis de novo and acid
sphingomyelinase activation; (iii) NGF induces the activation
of initiator and effector caspases and the hydrolysis of poly-
(ADP ribose) polymerase (PARP); (iv) only initiator caspases
are involved in ceramide generation; and (v) IGF-I prevents
NGF actions, at least in part, by decreasing intracellular
ceramide levels and activating Akt.
Materials and Methods
Materials
Human recombinant IGF-I was purchased from Roche Molecular
Biochemicals (Basel, Switzerland). Human recombinant IGF-I is
equipotent with chicken IGF-I when assayed in organotypic cultures
of chicken otic vesicles (León et al., 1998). Mouse 2.5S NGF was
routinely evaluated on chick embryo dorsal root ganglia (UBI, Lake
Placid, NY). Phosphatidic acid, from Sigma (St Louis, MO), was
handled as reported previously (Kishikawa et al., 1999). The antibody
to PCNA was from Concepta Biosystems, SA (Barcelona, Spain).
Anti-NGF mouse monoclonal antibody was from Roche Molecular
Biochemicals. The anti-p75NTR antibody utilised for
immunocytochemistry was from Santa Cruz Biotechnology (Santa
Cruz, CA). The blocking anti-p75NTR rabbit polyclonal antiserum
(9651) was made against the extracellular domain of mouse p75NTR,
whereas the non-blocking anti-p75NTR antibody (9992) recognises the
intracellular domain. The anti-p75NTR 9651 antibody blocks binding
of 125I-NGF to rat or mouse p75NTR in affinity crosslinking assays
(1:100 dilution) (Huber and Chao, 1995). Both antibodies were kindly
provided by M. V. Chao (Skirball Institute of Biomolecular Medicine,
New York University School of Medicine). The anti-PARP rabbit
polyclonal antibody was from Chemicon International Inc. (Temecula,
CA) and recognises both 116 kDa PARP and the apoptosis-related
cleavage fragment of 85 kDa. Anti-phospho-Akt (Ser473 and Thr308)
rabbit polyclonal antibodies were from New England Biolabs
(Beverly, MA) and anti-Akt goat polyclonal antibody was from Santa
Cruz Biotechnology Inc. Secondary antibodies conjugated with
horseradish peroxidase were purchased from Bio-Rad (Hercules, CA).
C2-ceramide (C2-Cer) was from Matreya Inc. (Pleasant Gap, PA),
whereas inactive C2-dihydroceramide and C8-ceramide-1-P (Cer-1-P)
were from Calbiochem (San Diego, CA). We used the t.l.c. system
described below to routinely test the presence of ceramide in
commercial Cer-1-P batches. The activity of the batches was tested in
parallel for the presence of oligonucleosomes in the cytosol, which
was taken as an index of DNA fragmentation. Only batches of
ceramide-free Cer-1-P were used. Cer-1-P was prepared in water and
sonicated before its addition to culture medium. [3H]palmitic acid (5
mCi/ml) was from Amersham Ltd. (Little Chalfont, England).
Fumonisin B1 (FB1), an inhibitor of ceramide synthesis de novo
(Herget et al., 2000), and desipramine, an inhibitor of acid
sphingomyelinase (Chatterjee and Wu, 2001), were from Sigma.
Manumycin A, an irreversible inhibitor of neutral sphingomyelinase
(Arenz et al., 2001), was from Calbiochem. R59949, an inhibitor of
diacylglycerol kinase (DGK), was from Calbiochem (San Diego, CA)
(Jiang et al., 2000).
The caspase inhibitors, zVAD-fmk (zVAD) (Calbiochem) and z-
DEVD-fmk (DEVD) (Enzyme Systems Products, Livermore, CA),
contain a peptide recognition sequence attached to a functional fluoro-
methylketone (fmk) group. These inhibitors are cell permeable and
act by binding irreversibly to the active site of caspases. zVAD is a
pan-caspase inhibitor, and DEVD is an inhibitor of ICE/CED-3 family
of cysteine proteases.
Preparation of organotypic cultures
Fertilized eggs from White-Leghorn hens, purchased at a local farm,
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were incubated at 38°C in a humidified atmosphere and were staged
according to Hamburger and Hamilton (HH) criteria (Hamburger and
Hamilton, 1951). Otic vesicles were dissected from chick embryos
corresponding to HH18 (embryonic day 2.5) and cultured in serum-
free M199 medium with Earle’s salts (Biowhitaker, Walkersville, MD)
supplemented with 2 mM glutamine (Biowhitaker) and antibiotics [50
IU/ml penicillin (Ern, Barcelona, Spain) and 50 m g/ml streptomycin
(CEPA, Madrid, Spain)]. Treatments with 4 nM NGF, 1 nM IGF-I, 5
m M C2-Cer, 5 m M dihydroceramide or 25 m M Cer-1-P were performed
in the absence or presence of the different antibodies or inhibitors at
37°C in a water-saturated atmosphere containing 5% CO. C2-Cer and
manumycin A were prepared in DMSO and desipramine was prepared
in methanol. The final concentration of DMSO or methanol in culture
medium was 0.01%, which had no detectable effect on otic vesicle
cultures. Otic vesicles cultured in medium without additions or, when
indicated, with solvents, were taken as control values. 
Western blot analysis
For western blotting, HH18 otic vesicles (1, 8 or 12 otic
vesicles/datapoint for PCNA, PARP or Akt immunodetection,
respectively) were made quiescent by incubation overnight in serum-
free medium. Treatments were carried out at 37°C for 16 hours for
PCNA and PARP analysis and 30 minutes for the Akt study.
Afterwards, otic vesicles were homogenised in Laemmli Buffer
(1.5 · ) with 1 mM phenylmethylsulfonyl-fluoride and frozen
immediately. Gels were loaded with solutions containing equal
amounts of proteins. Otic vesicle proteins were subjected to SDS-
PAGE on 8% polyacrylamide gels for PARP or 12% gels for PCNA
and Akt analysis. The electrophoresed proteins were transferred onto
PVDF membranes using a Bio-Rad Trans Blot according to the
manufacturer’s instructions. After incubation with blocking solution
(5% non-fat dry milk in Tris-buffered saline with 0.1% Tween 20),
blots were probed with the appropriate specific primary antibodies
for 2 hours at room temperature or overnight at 4°C. All antibodies
were diluted in blocking solution except anti-phospho-Akt
antibodies, which were diluted in Tris-buffered saline with 0.1%
Tween 20 containing 5% bovine serum albumine. Blots were
subsequently washed and then incubated with the adequate secondary
antibodies conjugated with peroxidase for 1 hour at room
temperature. The immunoblots were developed with a
chemiluminiscence system (Dupont-NEN, Boston, MA) and exposed
to X-ray film (Konica). Films were scanned in a Studio Scan II (Agfa)
and the bands were quantified by densitometry with NIH Image 1.59
software. 
Explant labelling and determination of ceramide levels
Otic vesicles were isolated from HH18 chick embryos and labelled
with 25 m Ci/ml of [3H]palmitic acid for 24 hours in the presence of
1% fetal bovine serum. They were then washed with PBS, placed in
serum-free medium and stimulated at 37°C with 4 nM NGF for 3
hours. Cellular lipids were extracted, and labelled ceramide was
purified as reported (Frago et al., 1998). Briefly, lipids were extracted
according to Bligh and Dyer (Bligh and Dyer, 1959), except that
phases were separated by adding 2 M KCl in 0.2 M H3PO4 instead of
water. The organic phase was dried under a N2 stream and the lipid
extracts were applied to thin-layer plates (silica Gel G60 t.l.c.), which
were developed twice with chloroform:methanol:acetic acid (9:1:1, by
volume). The material that co-migrated with cold ceramide standards
was scraped and extracted with 1 ml methanol/H2O (1:1 by volume).
Radioactivity associated with the spots was determined by
scintillation counting.
Assessment of apoptosis
Two techniques were used to study apoptotic cell death: TUNEL and
DNA fragment ELISA. Distribution of apoptotic cells in the otic
vesicle was determined by Tdt-mediated dUTP nick end labelling
(TUNEL) of the fragmented DNA with the modifications reported
previously (Blaschke et al., 1996) and adapted to whole organ
labelling (Frago et al., 1998; Díaz et al., 1999). Briefly, otic vesicles
were fixed overnight with 4% (w/v) paraformaldehyde in 0.1 M PBS
pH 7.4 and permeated by four incubations with 1% (w/v) Triton X-
100 in PBS for 30 minutes at room temperature and one incubation
with 20 m g/ml proteinase K (Roche Molecular Biochemicals) for 10
minutes at 37 ° C. The otic vesicles were then incubated with the
terminal deoxynucleotidyl-transferase buffer for 30 minutes at 37 ° C
and subsequently incubated with 0.1 U/ m l terminal deoxynucleotidyl-
transferase and 10 m M biotin-16-deoxy-UTP (Roche Molecular
Biochemicals) for 2.5 hours at 37 ° C. The reaction was stopped by
incubation with 2 mM EDTA in PBS for 1 hour at 65 ° C. TUNEL
labelling was visualized by incubation with Cy2-streptavidin
(Amersham Pharmacia Biotech, Rainham, Essex, UK), which was
followed by transparentation with 70% glycerol in PBS (v/v) and
mounting for epifluorescence. Fluorescence was analysed in a
MRC1024 BioRad confocal microscope. At least five otic vesicles
per condition were assayed in three different experiments. In parallel,
TUNEL assays on 25 m m cryostat sections of HH18 chicken embryos
were performed essentially by following manufacturer’s instructions
(In situ Cell Death detection kit, POD, Roche Molecular
Biochemicals), as described previously (Sanz et al., 1999a). Briefly,
sections were fixed in 4% paraformaldehyde (w/v) for 20 minutes
and then rinsed in 0.1% Triton X-100 with 0.1% sodium citrate for
2 minutes. Sections were then incubated with the terminal
deoxynucleotidyl transferase enzyme in buffer containing fluorescein
nucleotides for 1 hour at 37°C. The TUNEL signal was visualized
with an antibody antifluorescein coupled to peroxidase for 30
minutes at 37°C. At least nine embryos were sampled in three
different assays. 
Otocyst cell death was quantified by using the Cell Death Detection
ELISA (Roche Molecular Biochemicals), which was based on the
detection of histone-associated DNA fragment in the cytoplasm of
cells. Quiescent HH18 otic vesicles were cultured in serum-free
medium with different additives for 16 hours and then processed for
apoptosis determination. A single HH18 cultured otic vesicle was
homogenised in 100 m l of the supplied incubation buffer and the cell
extracts subjected to ELISA determination following basically the
instructions of the supplier.
Whole mount in situ hybridization
In situ hybridisation was performed on chicken embryos as described
previously (Wilkinson, 1992). A single-stranded chicken p75NTR
RNA probe (A. Rodríguez-Tebar, Instituto Cajal, Madrid, Spain) was
prepared by transcription of the linearized plasmid pKS-p75 with
XbaI, using T3 RNA polymerase (Promega, Madison, WI) (Large et
al., 1989). The control sense probe was prepared by using T7 RNA
polymerase (Promega, Madison, WI) after linearizing pKS-p75 with
HindIII. Embryos were incubated overnight at 70°C with 1 m g/ml
digoxigenin-labelled RNA p75NTR probe in hybridization mix (50%
formamide, 1.3· SSC pH 4.5, 5 mM EDTA, 50 m g/ml yeast RNA,
0.2% Tween 20, 0.5% CHAPS and 100 m g/ml heparin). To elicit
colour, embryos were incubated with a 1/2000 dilution of anti-
digoxigenin-alkaline phosphatase antibody (Roche Molecular
Biochemicals). Colour was developed with 0.26 mg/ml nitroblue
tetrazolium chloride and 0.175 mg/ml 5-bromo-4-chloro-3 indolyl-
phosphate prepared in NTMT (100 mM NaCl, 100 mM Tris-HCl pH
9.5, 50 mM MgCl2 and 0.1% Tween 20). For histological
examination, embryos were post-fixed in 4% paraformaldehyde,
embedded in gelatine-albumin and sectioned with a vibratome (Leica
VT 1000M, Heidelberg, Germany) at a thickness of 60 m m. At least
12 embryos were sampled in three different experiments.
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Immunocytochemistry
Immunocytochemistry was performed on frozen sections obtained
from HH18 chicken embryos fixed overnight in 4% paraformaldehyde
(w/v), dehydrated in 30% sucrose and then included in Tissue Teck
(Miles Diagnostics Div., Kankakee, IL). Frozen embryos were
sectioned at a thickness of 20 m m with a cryostat (Leitz, Jena,
Germany). Sections were placed on polylysine-coated slides and
processed for p75NTR receptor analysis following the procedures
previously described (Casaccia-Bonnefil et al., 1996; Sanz et al.,
1999a). Briefly, sections were incubated in 3% H2O2 in methanol for
20 minutes and then blocked in a solution of 0.1% Triton X-100 in
PBS containing 10% goat serum for 1 hour. Sections were left
incubating overnight with rabbit polyclonal anti-p75NTR antibody
(1/1000 in the blocking solution) in a humid chamber at 4°C.
Afterwards sections were incubated in EnVision+ anti-rabbit
peroxidase-conjugated secondary antibodies (Dako, Copenhagen,
Denmark) for 30 minutes and peroxidase was developed with 0.5
mg/ml diaminobenzidine tetrahydrochloride (Sigma) and 0.01%
H2O2. At least 10 embryos were analyzed in three different
experiments.
Results
IGF-I counteracts NGF-induced apoptosis in cultured
otic vesicles
The dynamic balance between proliferation and programmed
cell death during early otic development is carefully regulated
(Alvarez and Navascués, 1990; Fekete et al., 1997; Sanz et al.,
1999a). We have previously demonstrated that IGF-I promotes
both proliferation and survival in the cultured otocyst, whereas
NGF acts as an apoptosis-inducing factor (Frago et al., 1998;
Sanz et al., 1999a). Therefore, we here explore the possible
interactions between the pathways activated by IGF-I to
prevent apoptosis and those activated by NGF to induce cell
death.
The first step was to study the resulting effect when both
factors were acting together on cultured otic vesicles. As
shown in Fig. 1, NGF increased the number of TUNEL-
positive cells, particularly at the ventromedial wall of the otic
vesicle, where the CVG is emerging (Fig. 1, compare B with
A) and within the CVG. C2-Cer addition induced cell death
with a less restricted pattern (Fig. 1C). IGF-I not only
effectively reduced cell death caused by serum deprivation
(Fig. 1, compare D with A), but it was also able to prevent
apoptosis induced by NGF and C2-Cer (Fig. 1E,F).
Expression of p75NTR in the developing inner ear
Once the epistatic effect of IGF-I on NGF was demonstrated,
we characterized some of the pathways activated by NGF
during cell death induction in the otic vesicles to later analyze
the sites blocked by IGF-I. The presence of NGF receptors in
the otic vesicle epithelium and CVG has been reported in
several species (Hallbook et al., 1990; von Bartheld et al.,
1991; Schecterson and Bothwell, 1994; Wu and Oh, 1996). We
extended these reports by assessing the presence of p75NTR
transcripts in HH18 chicken otic vesicles by whole mount in
situ hybridization and immunohistochemistry (Fig. 2). The
expression of p75NTR transcripts and protein was high in
restricted areas of the otic vesicle epithelium and within the
CVG (Fig. 2A,B). p75NTR expression was also high in the
mesenchyme surrounding the otocyst. Furthermore, apoptotic
cell death was detected in the same areas both in vivo and in
cultured otic vesicles treated with NGF (Fig. 2C-E). Therefore,
p75NTR was expressed within the areas of high cell death in the
otocyst at the developmental stage studied.
p75NTR and caspase activation mediate NGF-induced
apoptosis in the otic vesicle
The involvement of p75NTR in NGF pro-apoptotic actions was
studied by using the 9651 anti-p75NTR antibody, which
effectively blocks NGF binding to p75NTR (Huber and Chao,
1995). The levels of cytoplasm-soluble nucleosomes were
measured in otic vesicle extracts to quantify cell death caused
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Fig. 1. IGF-I protects otic vesicles from NGF-
induced cell death. Apoptotic cell death was
visualised by TUNEL in cultured otic vesicles.
Otic vesicles were isolated from HH18 chicken
embryos, made quiescent and cultured for 8
hours in serum-free medium (A, control), 4 nM
NGF (B), 5 m M C2-Cer (C) or 1 nM IGF-I (D) or
the combination of IGF-I with NGF (E) or C2-
Cer (F). Compiled projections of the whole otic
vesicle are shown. All otic vesicles have the
same orientation: D (dorsal), A (anterior), cvg
(cochleovestibular ganglion). The images shown
are representative of at least three different
experiments, using five otic vesicles by
condition. Bar, 100 m m.
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by treatment with NGF or NGF plus anti-p75NTR antibodies.
Table 1 shows that apoptosis induced by NGF was completely
prevented by the 9651 anti-p75NTR antibody but not by
treatment with the control non-blocking 9992 anti-p75NTR
antibody. These results indicate that in the otic vesicle the
apoptotic response to NGF requires binding to p75NTR. In
addition, the specificity of NGF actions was confirmed by
culturing the otic vesicle explants in the presence of NGF plus
anti-NGF antibody. Under these conditions, NGF did not
induce cell death. Treatment of otic vesicles with any of these
antibodies alone had no appreciable effect (Table 1). Therefore,
NGF effects on otic vesicle apoptosis are specific for this
neurotrophic factor and are mediated through binding to
p75NTR.
To evaluate the implication of caspases in p75NTR-dependent
NGF-induced cell death, otic vesicles were cultured in the
presence of caspase inhibitors, which completely suppressed
death induced by NGF (Table 2). Treatment of otic vesicles
with either zVAD (25 m M) or DEVD (75 m M) completely
blocked NGF-induced apoptosis, whereas the addition of
zVAD or DEVD had no effect on basal cell death. Caspase
inhibitors also prevented C2-Cer-induced cell death. The
specificity of C2-Cer actions was tested using
dihydroceramide, an inactive synthetic analogue of C2-Cer.
The addition of 5 m M dihydroceramide had no effect on the
relative amount of oligonucleosomes in the cytoplasm,
indicating that C2-Cer actions were specific (Table 2). 
TUNEL staining of cultured otic vesicles confirmed these
results (Fig. 3). Otic vesicles cultured in serum-free medium
presented basal levels of cell death, whereas NGF treatment
increased the number of TUNEL-positive cells (Fig. 3A,B). By
contrast, pre-treatment with either anti-NGF antibodies or anti-
p75NTR blocking antibodies led to a significant reduction in cell
death when compared with otic vesicles cultured with NGF
alone (Fig. 3B-D). Pre-treatment of the otic vesicles with
caspase inhibitors also blocked NGF-induced apoptosis in the
otic vesicle epithelium and the CVG (Fig. 3F,H). Treatment
Fig. 2. p75NTR is expressed in the developing inner ear. (A) p75NTR mRNA expression was detected by whole mount in situ hybridization in
HH18 chicken embryos. Arrowheads point to major patches of p75 expression, within the otic epithelium and in the CVG (cvg). The
microphotograph shows a 60 m m parasagittal vibratome section. At least 12 embryos were sampled in three different experiments.
(B) Immunolocalization of p75NTR protein was positive in the otic epithelium and in the CVG (arrowheads). The microphotograph shows a 25
m m parasagittal section from an HH18 chicken embryo. At least 10 embryos were sampled in three different experiments. (C,D) Detection of
apoptotic cells by TUNEL labelling in a 25 m m parasagittal cryostat section from an HH18 embryo. D shows a magnification of the CVG area.
(E) 2.5 m m optic section of an otic vesicle cultured in the presence of 4 nM NGF. Apoptotic positive cells were visualised by TUNEL labelling.
C and E arrowheads point to apoptotic cells in the otic epithelium and CVG. C and E microphotographs are representative of at least three
different experiments performed in triplicate. A, anterior; D, dorsal; cvg marks the CVG area. Bar, 100 m m (A, B, C and E), 50 m m (D).
Table 1. NGF-induced cell death is mediated by p75NTR in
the otic vesicle 
Control 100 (n=13)
NGF 149±5** (n=13)
NGF + a NGF 118±6# (n=5)
NGF + [9651] a p75 97±11# (n=8)
NGF + [9992] a p75 133±5* (n=8)
a NGF 107±13# (n=6)
[9651]a p75 88±16# (n=5)
[9992]a p75 98±6# (n=8)
Otic vesicles were isolated from HH18 chicken embryos, made quiescent
by an overnight incubation in serum-free medium and treated with NGF (4
nM), a NGF (2 µg/ml), [9651]a p75 (1:100) or the non-blocking antibody
[9992]a p75 (1:100) for 16 hours. Soluble nucleosomes were quantified in
single otic vesicle explants. For each experiment the absorbance obtained in
the absence of serum (control) was given a value of 100. n is the total number
of explants tested in at least three different experiments. Values are expressed
as mean±s.e.m. Statistical significance estimated by ANOVA was as follows:
** P<0.005 versus control, * P<0.05 versus control and #P<0.005 versus NGF.
Table 2. Involvement of caspases in p75NTR and C2-Cer-
dependent cell death
Control 100 (n=17)
NGF 149±5* (n=13)
NGF + zVAD 80±12# (n=8)
NGF + DEVD 101±6# (n=16)
C2-Cer 176±7 * (n=19)
C2-Cer + zVAD 116±4§ (n=10)
C2-Cer + DEVD 122±7§ (n=13)
Dihydroceramide 109±1 (n=3)
ZVAD 80±12 (n=9)
DEVD 94±21 (n=11)
Quiescent HH18 otic vesicles were treated for 16 hours with NGF (4 nM),
C2-Cer (5 µM) or dihydroceramide (5 µM) alone or in combination with
either zVAD (25 µM) or DEVD (75 µM) as indicated. To quantify cell death
soluble nucleosomes were measured as described in the Materials and
Methods section. For each experiment the absorbance obtained in the absence
of serum (Control) was given a value of 100. n is the total number of explants
tested in at least three different experiments. Values are presented as
mean±s.e.m. Statistical significance estimated by ANOVA was as follows:
* P<0.005 versus Control,  #P<0.005 versus NGF and §P<0.005 versus C2-
Cer.
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with either the antibodies or the inhibitors alone had no effect
(data not shown and Fig. 3E,G, respectively).
To further explore NGF-p75NTR downstream signalling,
intracellular ceramide levels and PARP cleavage were
determined in the absence or presence of anti-p75NTR
antibodies, anti-NGF antibodies or caspase inhibitors (Fig. 4).
Treatment with either anti-NGF or 9651 anti-p75NTR
antibodies impaired NGF induction of ceramide accumulation
(Fig. 4A). The next step was to study the roles of the caspase
subfamilies in the generation of endogenous ceramide. Fig. 4A
shows that zVAD, but not DEVD, was able to impair the
increase in ceramide levels caused by NGF. Therefore, these
data suggest that the increase in the intracellular ceramide
content produced by NGF is secondary to the activation of a
subset of zVAD-sensitive DEVD-insensitive caspases, most
probably initiator caspases. The degree of PARP cleavage to
the 85 kDa PARP fragment, a marker of caspase-3-dependent
apoptosis (Lazebnik et al., 1994), was also determined in otic
vesicles cultured under different conditions. NGF increased the
proteolytic cleavage of PARP by 2.6-fold, which was prevented
by pre-treatment with either blocking anti-p75NTR antibodies
or caspase inhibitors (Fig. 4B). PARP cleavage was also
increased in otic vesicles cultured in the presence of C2-Cer by
4.5-fold, and this was again prevented by treatment with
caspase inhibitors (Fig. 4C). Taken together these results
suggest that following NGF binding to p75NTR, initiator
caspases are activated. This activation will lead to an increase
in intracellular ceramide content that in turn will stimulate
effector caspase-3-like proteases, leading to PARP
degradation, DNA fragmentation and cell death. 
NGF-induced cell death is dependent on ceramide
generation
Next we examined the intracellular source of the ceramide
released by the action of NGF (Fig. 4A). FB1 (50 m M), an
inhibitor of de novo ceramide synthesis, reduced the NGF-
dependent increase in ceramide levels by 50% and was also
able to impair NGF-dependent cell death (Table 3).
Desipramine (10 m M), an acid sphingomyelinase inhibitor, was
also able to impair NGF actions by decreasing ceramide levels
by 52% and blocking cell death (Table 3). On the other hand,
the neutral sphingomyelinase inhibitor manumycin A did not
cause any effect at the doses tested (10 to 100 m M, data not
shown).
IGF-I activates Akt and blocks NGF-induced ceramide
increase 
Finally, we explored the crosstalk between the IGF-I and NGF
intracellular pathways. Treatment of cultured otic vesicles with
IGF-I prevented NGF-induced ceramide accumulation (Fig.
4A; Fig. 5A). Ceramide is phosphorylated in vivo by a
ceramide kinase to give Cer-1-P (Dressler and Kolesnick,
1990), which is a cytoprotector for the otocyst (Frago et al.,
1998). In vitro, bacterial DGK carries out the same reaction
(Schneider and Kennedy, 1973). Ceramide kinase has been
recently cloned, purified and its biochemical activity
characterized in vitro (Sugiura et al., 2002). Ceramide kinase
has a DGK catalytic domain (Sugiura et al., 2002), which is
the target of the DGK inhibitor R59949 (Jiang et al., 2000). To
test whether IGF-I is further controlling intracellular ceramide
levels by modulating ceramide phosphorylation, otic vesicle
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Fig. 3. p75NTR and caspases are involved in NGF-induced cell death in the otic vesicle. Apoptotic cell death was visualised by TUNEL. Otic
vesicles were isolated from HH18 chicken embryos, made quiescent and cultured for a further period of 8 hours in serum-free medium (A,
Control) or 4 nM NGF (B) alone or in combination with 2 m g/ml anti-NGF antibody (C), (1:100) 9651 anti p75NTR antibody (D) or caspase
inhibitors, 25 mM zVAD (F) and 75 mM DEVD (H), as indicated in the panels. Explants were pre-treated for 30 minutes with the antibodies or
caspase inhibitors. All the otic vesicles have the same orientation: D (dorsal); A (anterior); cvg (cochleovestibular ganglion). Compiled
projections of the whole otic vesicle are shown. Representative microphotographs of three independent experiments using five otic vesicles by
condition are shown. Bar, 100 m m.
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cultures were treated with R59949, which produced a slight
increase in basal apoptotic cell death but was unable to affect
IGF-I actions (Table 4). The cytoprotective effect of Cer-1-P is
shown for comparison (Table 4). In the presence of either NGF
or C2-Cer, R59949 effectively impaired the survival actions of
IGF-I. Moreover, treatment with R59949 blocked the actions
of IGF-I on NGF-induced increase in ceramide levels (Fig. 5A)
and on the activation of JNK (data not shown). IGF-I prevents
JNK activation induced by both serum deprivation and NGF
(Sanz et al., 1999a). These results suggest that the protective
effect of IGF-I on cell death may be mediated by inducing
ceramide phosphorylation. 
Activation of the pathway initiated by phosphorylation of the
Akt serine/threonine kinase by IGF-I is central to cell survival
(Dudek et al., 1997; Zheng et al., 2000). In cultured otic
vesicles, IGF-I effectively stimulated the phosphorylation of
Akt at Ser473 (4.7-fold) and Thr308 (4-fold) residues (Fig. 5B
and data not shown, respectively). NGF and C2-Cer did not
induce changes in the levels of Akt phosphorylation and were
unable to alter the induction by IGF-I of the phosphorylation
at Ser473-Akt (4.1- and 3.5-fold, respectively) and Thr308
(3.8- and 2.3-fold, respectively) (Fig. 5B and data not shown).
However, pre-treatment with R59949 plus NGF or C2-Cer
decreased IGF-I-induced Ser473- and Thr308-Akt
phosphorylation (2.8- and 2.2-fold, respectively for Ser473-
Akt phosphorylation; 2.2- and 1.2-fold for Thr308-Akt
phosphorylation), whereas in the absence of IGF-I R59949
alone or in combination with NGF had no effect (data not
shown). Treatment with Cer-1-P also increased Akt
phosphorylation levels by 2.7- and 1.9- fold at Ser473 and
Thr308 residues, respectively. On the other hand, phosphatidic
acid (10-50 m M), the natural product of DGK, had no effect on
Akt phosphorylation (25 m M, 0.9±0.2 fold) at the same time
points. Changes in the degree of phosphorylation of Akt were
paralleled by changes in the levels of PCNA, a marker of cell
proliferation (Fig. 5B). 
Discussion
In summary, here we show that: (i) p75NTR is expressed in the
Fig. 4. Modulation of NGF-induced ceramide accumulation and
PARP hydrolysis. (A) Modulation of ceramide accumulation by
NGF. Five HH18 otic vesicles/per datapoint were labelled with 25
m Ci/ml of [3H]palmitic acid for 24 hours as described in Materials
and Methods. Otic vesicles were then carefully washed and
incubated for 3 hours without additives (control) or with 4 nM NGF
alone or in combination with 1 nM IGF-I, 2 m g/ml anti-NGF
antibody, 9651 anti-p75NTR antibody (1:100), 25 m M zVAD or 75
m M DEVD. Ceramide accumulation was measured as described in
Materials and Methods. Results are expressed as mean±s.e.m. of at
least five independent experiments performed in triplicate. Statistical
significance estimated by ANOVA was as follows *P<0.005 versus
control, #P<0.005 versus NGF. (B) NGF-induced cell death triggers
PARP-hydrolysis. Hydrolysis of native poly-ADP-ribose polymerase
(p116-PARP) produces a fragment of 85 kDa (p85-PARP). Quiescent
HH18 otic vesicles (8 otic vesicles per data point) were incubated for
16 hours either in serum-free medium (Control) or in the presence of
4 nM NGF alone or in combination with 1 nM IGF-I, 2 m g/ml anti-
NGF antibody, 9651 (1:100) anti-p75NTR antibody, 25 m M zVAD or
75 m M DEVD. Incubation with the non-blocking p75NTR antibody or
agonist vehicles had no effect on PARP induction (data not shown).
Otic vesicle lysates were analysed by western blotting with an anti-
PARP antibody that recognizes both the intact and the proteolysis
fragment. A representative blot of one of three independent
experiments is shown. Densitometric quantification is shown as bars.
Statistical significance estimated by ANOVA was as follows
*P<0.005 versus control, #P<0.005 versus NGF. (C) C2-Cer-induced
cell death also triggers PARP-hydrolysis. Otic vesicles were
incubated in serum-free medium (Control) or 5 m M C2-Cer alone or
in combination with 1 nM IGF-I, 25 m M zVAD or 75 m M DEVD.
Otic vesicle lysates were analysed by western blotting with an anti-
PARP antibody as above. A representative blot of one of three
independent experiments is shown. Densitometric quantification is
shown as bars. Statistical significance estimated by ANOVA was as
follows *P<0.005 versus control, #P<0.005 versus C2-Cer.
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otic vesicle epithelium and CVG; (ii) NGF-induced apoptosis
in the otic vesicle is p75NTR dependent, since cell death can be
prevented by blocking the p75NTR extracellular domain; (iii)
NGF induces ceramide generation by activating both de novo
synthesis and acid sphingomyelinase activity; (iv) initiator and
effector caspases are involved in NGF-induced cell death; and
(v) the protective role of IGF-I on NGF-induced cell death is
accompanied by a decrease in the intracellular levels of
ceramide and inducing phosphorylation of the Akt kinase.
Cell death, which normally takes the route of apoptosis, is a
physiological process during development and morphogenesis
(Raff et al., 1993). Apoptosis can be induced or prevented by
a variety of stimuli that activate different intracellular
signalling pathways, which converge to activate or inhibit a
common pool of executioner molecules. Analysis of many
linear intracellular signal transduction and apoptotic pathways
has been the object of intense research. But how and where
they intersect and whether this crosstalk results in synergy or
antagonism is not known in most cellular contexts. Therefore,
determining the sequence of events and the interdependencies
involved in apoptosis signalling is an area of active research. 
Among the neuronal pro-apoptotic factors, considerable
attention is presently focused on NGF and its low-affinity
receptor, p75NTR. It has been proposed that the relative levels
of high- and low-affinity NGF receptors determine cell fate
(Lee et al., 2001; Chao and Bothwell, 2002). The cellular
response to NGF will, therefore, depend on the developmental
modulation of NGF receptors expression. In the present study,
we show that in the otic vesicle NGF-induced apoptosis is
mediated by binding to p75NTR. A similar situation has been
reported for embryonic retinal cells and postnatal
oligodendrocytes where activation of p75NTR increases cellular
apoptosis (Casaccia-Bonnefil et al., 1996; Frade et al., 1996;
Frade, 2000; González-Hoyuela et al., 2001). In the otocyst,
after binding to p75NTR, NGF increases ceramide levels, and
this increase can be reduced by treatment with inhibitors of
acid sphingomyelinase and de novo synthesis. p75NTR-induced
apoptosis has been shown to trigger ceramide generation in
different neural cell types including oligodendrocytes and
neuroblastoma cells (Dobrowsky et al., 1994; Dobrowsky et
al., 1995; Casaccia-Bonnefil et al., 1996; Lievremont et al.,
1999). Although earlier studies pointed to a membrane-neutral
sphingomyelinase associated with p75NTR as the enzyme
responsible for ceramide increase (Brann et al., 1999;
Dobrowsky and Carter, 2000), such an enzyme has not yet been
characterized and our results indicate that, in the otic vesicle,
NGF actions are dependent on both the full activity of an acid
sphingomyelinase and on an increase in de novo ceramide
synthesis. These results are in agreement with the sustained
increase in ceramide levels (up to 4 hours) induced by NGF in
this system (Frago et al., 1998). Acid sphingomyelinase
participates in stress-activated and developmental apoptosis
(Peña et al., 1997; Morita et al., 2000; Cutler and Mattson,
2001) and p75NTR overexpression induces cell survival in
human Niemann-Pick fibroblasts, which lack acid
sphingomyelinase activity (Roux et al., 2001). On the other
hand, de-novo-synthesized ceramide has been reported to be
crucial for apoptosis in different cellular settings including
during early neural differentiation (Herget et al., 2000; Gomez
del Pulgar et al., 2002). 
Several studies indicate that ceramide generation is essential
for apoptosis, but there are discrepancies concerning whether
ceramide generation is upstream or downstream of caspases
activation (Chinnaiyan et al., 1996; Mizushima et al., 1996;
Hartfield et al., 1998). Some groups studying secondary
cultures of adult cells have concluded that ceramide action is
downstream of the initiator caspases but upstream from the
executioner caspases, such as caspase-3 (Sweeney et al., 1998;
Grullich et al., 2000; Craighead et al., 2000). Caspase-3 is
thought to be primarily required for the nuclear changes that
occur during apoptosis (Oppenheim et al., 2001). Furthermore,
recent studies show that ceramide induces non-apoptotic
programmed cell death with necrotic-like morphology
(Mochizuki et al., 2002). We have studied NGF-induced
ceramide generation in the presence of caspase inhibitors in
organotypic cultures of the developing otocyst. We show that
after NGF binding to p75NTR only zVAD was capable of
blocking NGF-induced ceramide release. On the other hand,
PARP-cleavage and cell death were impaired by both zVAD
and DEVD, suggesting that the activation of both initiator and
caspase-3-like proteases is required for PARP hydrolysis and
cell death. Therefore, the activation of the caspase-3 occurs
downstream of the increase in intracellular ceramide content
produced in response to NGF. These data suggest that an
increase in ceramide could be a secondary signal activated by
caspases and capable of further activating these proteases. The
ceramide increase may, therefore, be a reinforcement loop to
commit cells to apoptosis. 
In the otic vesicle, the survival actions of IGF-I are
independent from the stimuli responsible for the initiation of
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Table 3. NGF-induced cell death is ceramide generation dependent
pmoles [3H]ceramide/ m g protein Cell death
Control 3640±216 (n=6) 100 (n=6)
NGF 5522±355* (n=6) 154±9* (n=6)
NGF + FB1 4576±350 (n=6) 115±4## (n=7)
NGF + Desipramine 4556±335 (n=6) 109±15# (n=6)
FB1 3053±622 (n=3) 90±6 (n=3)
Desipramine 3680±11 (n=3) 101±18 (n=4)
Otic vesicles were dissected from HH18 chick embryos. For the cell death assays otic vesicles were deprived of serum and cultured for 16 hours with NGF (4
nM) or NGF plus 50 m M fumonisin B1 (FB1) or 10 m M desipramine. One hour of pre-treatment was performed in those conditions where inhibitors were used.
Quantification of nucleosomes was performed in single otic vesicle explants and was normalized versus the control. n is the total number of explants tested in at
least two different experiments. Ceramide generation was evaluated in parallel experiments as described in Materials and Methods. Values are expressed as
mean±s.e.m; n represents the total data point number with five otic vesicle explants per point. Statistical significance estimated by ANOVA was as follows:
*P<0.005 versus control, ##P<0.005 versus NGF, #P<0.05 versus NGF.
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apoptosis, protecting it from serum withdrawal, NGF
and C2-Cer-induced cell death. Igf-1-knockout mice
show increased apoptosis and activated caspase-3 in the
cochlear ganglia (Camarero et al., 2001). By contrast,
transgenic mice that overexpress IGF-I present
decreased levels of activated caspase-3 and a general
impairment in apoptotic pathways (Chrysis et al., 2001).
In parallel to these studies, it is known that a major
pathway for the anti-apoptotic actions of IGF-I is the
activation of the Akt kinase (Dudek et al., 1997).
Phosphorylation of Akt at threonine 308 by
phosphoinositide-dependent kinase 1 is followed by
autophosphorylation at serine 473 to produce an
activated Akt whose role is to facilitate survival by
phosphorylation of downstream substrates (Brazil and
Hemmings, 2001). Akt kinase plays a crucial role in
supporting NGF-dependent survival through Trk
receptors, whereas activation of the p75NTR receptor can
initiate a cell death cascade in neurons and glial cells
(Kaplan and Miller, 2000). Here we show that IGF-I acts
at different levels to protect otic vesicles from NGF-
induced cell death. First, IGF-I blocks the intracellular
increase in ceramide generation elicited by NGF and
second, IGF-I activates Akt. Therefore, the protective
role of IGF-I in p75NTR-dependent cell death is, at least
in part, mediated by decreasing ceramide levels with a
concomitant activation of Akt phosphorylation. Cer-1-P,
a molecule that is reported to be a cytoprotector for otic
vesicle explants, also activated Akt. The crosstalk
between PI 3-kinase, an enzyme upstream in the
intracellular cascade of Akt, and the sphingomyelinase
pathways has been shown to be important for the balance
between cell survival and death decisions (Burow et al.,
2000). Indeed, PI 3-kinase downregulation by stress is
dependent on acid sphingomyelinase (Zundel and
Giaccia, 1998). C2-Cer has been reported to inhibit Akt
activity (Schubert et al., 2000; Teruel et al., 2001);
however, in the otic vesicle, IGF-I is able to protect the
otocyst from C2-Cer-induced apoptosis, suggesting that
in addition to Akt activation there is another
mechanism(s) by which IGF-I blocks cell death induced
by exogenous C2-Cer. One possible fate for ceramide is
conversion to Cer-1-P by ceramide kinase, which has a
DGK catalytic domain (Sugiura et al., 2002). By using
R59949 we have explored the possibility that the
protective effects of IGF-I on otic vesicle survival could
be due to an increase in Cer-1-P. In the presence of
R59949, the protective action of IGF-I against apoptosis
induced by NGF or C2-Cer was lost, and this is
associated with an increase in NGF-induced endogenous
ceramide levels. Other lipid mediators such as
phosphatidic acid or sphingosine-1-phosphate have no
significant survival actions in this system as shown here
and previously (Frago et al., 1998). These data suggest
that IGF-I enhances the conversion of the pro-apoptotic
ceramide to its phosphorylated cytoprotective metabolite
Cer-1-P; therefore, the relative levels of ceramide and
Cer-1-P could be an intracellular indicator for cell
death/survival decisions. 
Our results indicate that during the early development
of the chicken inner ear the signalling pathways induced
Fig. 5. IGF-I increases Akt phosphorylation and PCNA levels.
(A) Modulation of NGF-induced ceramide accumulation by R59949.
Ceramide accumulation was measured as described in Materials and
Methods. Otic vesicles were incubated for 3 hours without additives
(Control), 1 nM IGF-I, 1 m M R59949 or with 4 nM NGF alone or in
combination with IGF-I and R59949. Statistical significance estimated by
ANOVA was as follows *P<0.005 versus control, #P<0.005 versus NGF.
(B) Quiescent HH18 otic vesicles were incubated for 30 minutes with 1 nM
IGF-I, 4 nM NGF, 5 m M C2-Cer, 25 m M Cer-1-P or combinations of these
factors for the determination of Akt or for 24 hours to measure PCNA levels.
When indicated, a 30 minute pre-treatment with 1 m M R59949 was
performed. Otic vesicle lysates were analysed by western blotting for total
Akt levels, for the active phosphorylated form of Akt (Ser473 P-Akt) and for
PCNA levels. Representative blots are shown. The lower panel shows
densitometric quantification values of activated Akt (Akt-P) referred to total
Akt levels (grey bars) and of PCNA (dark bars). Control cultures were taken
as 100. Values are given as mean±s.e.m. of independent experiments
performed in duplicate. The statistical significance between incubations
under different conditions estimated by ANOVA was as follows: *P<0.005
versus control, #P<0.001 versus IGF-I. R59949 plus IGF-I and NGF or C2-
Cer were statistically significant (P<0.001) with respect to their equivalent
R59949-untreated conditions. 
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by NGF and IGF-I form a complex network that regulates
apoptotic cell death, a likely scenario for the regulation of early
neural cell death (Fig. 6). We provide evidence that the
molecular basis for the restricted apoptotic response to NGF in
the otocyst involves modulation of the activation of death
p75NTR versus survival receptors. Activation of survival
signalling pathways implies blockage of the apoptotic
pathways at several levels. Hence, some aspects of the
regulation of inner ear development appear to occur thanks to
the crosstalk between NGF and IGF-I signalling. We propose
that the dynamic balance between levels of ceramide
metabolites and the consequent regulation of Akt
phosphorylation are important factors that determine whether
a cell survives or dies.
This work was supported in part by grants from Dirección General
de Investigación, Ciencia y Tecnología (PM99-0111) to I. V-N and
(PM99-0094) to E. J. de la R. L.M.F. was supported by Europharma
(Boehringer Ingelheim Inc.), Y.L. held a CSIC research contract and
S.C. was supported by the Comunidad de Madrid. We are grateful to
Julie A. Chowen, Ana Cuadrado, Flora de Pablo, David Jones, Isabel
Merida and Agustin Rodríguez for helpful comments on this
manuscript.
References
Alvarez, I. and Navascués, J. (1990). Shaping, invagination and closure of
the chick embryo otic vesicle: Scanning electron microscope and
quantitative study. Anat. Rec. 228, 315-326.
Arenz, C., Thutewohl, M., Block, O., Waldmann, H., Altenbach, H.-J. and
Giannis, A. (2001). Manumycin A and its analogues are irreversible
inhibitors of neutral sphingomyelinase. Chembiochem. 2, 141-143.
Barrett, G. L. (2000). The p75 neurotrophin receptor and neural apoptosis.
Prog. Neurobiol. 61, 205-229.
Beutler, B. and van Huffel, C. (1994). Unraveling function in the TNF ligand
and receptor families. Science 264, 667-668.
Bibel, M. and Barde, Y. (2000). Neurotrophins: key regulators of cell fate and
cell shape in the vertebrate nervous system. Genes Dev. 14, 2919-2937.
Bissonnette, J. P. and Fekete, D. M. (1996). Standard atlas of the gross
anatomy of the developing inner ear of the chicken. J. Comp. Neurol. 368,
620-630.
Blaschke, A. J., Staley, K. and Chun, J. (1996). Widespread programmed
cell death in proliferative and postmitotic regions of the fetal cerebral cortex.
Development 122, 1165-1174.
Bligh, E. G. and Dyer, W. J. (1959). A rapid method of total lipid extraction
and purification. Can. J. Biochem. Physiol. 37, 911-917.
Brann, A. B., Scott, R., Neuberger, Y., Abulafia, D., Boldin, S., Fainzilber,
M. and Futerman, A. H. (1999). Ceramide signalling downstream of the
p75 neurotrophin receptor mediates the effects of nerve growth factor on
outgrowth of cultured hippocampal neurons. J. Neurosci. 19, 8199-8206.
Brazil, D. P. and Hemmings, B. A. (2001). Ten years of protein kinase B
signalling: a hard Akt to follow. Trends Biochem. Sci. 26, 657-664.
Burow, M. E., Weldon, C. B., Collins-Burow, B. M., Ramsey, N., McKee,
A., Klippel, A., McLachlan, J. A., Clejan, S. and Beckman, B. S. (2000).
Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase
pathways as a mechanism for cell survival/death decisions. J. Biol. Chem.
275, 9628-9635.
Camarero, G., Avendaño, C., Fernández-Moreno, C., Villar, A., Contreras,
J., de Pablo, F., Pichel, J. G. and Varela-Nieto, I. (2001). Delayed inner
ear maturation and neuronal loss in postnatal Igf-1-deficient mice. J.
Neurosci. 21, 7630-7641.
Casaccia-Bonnefil, P., Carter, B. D., Dobrowsky, R. T. and Chao, M. V.
(1996). Death of oligodendrocytes mediated by the interaction of nerve
growth factor with its receptor p75. Nature 383, 716-719.
Casaccia-Bonnefil, P., Gu, A., Khursigara, G. and Chao, M. V. (1999). The
p75 neurotrophin receptor as a modulator of survival and death decisions.
Microsc. Res. Tech. 45, 217-224.
Chao, M. V. and Bothwell, M. (2002). Neurotrophins: to cleave or not to
cleave. Neuron 33, 9-12.
Chatterjee, M. and Wu, S. (2001). Cell line dependent involvement of
Journal of Cell Science 116 (3)
Table 4. IGF-I protective effects on cell death induced by
NGF and C2-Cer 
Control 100 (n=9)
IGF-I 84±5* (n=9)
R59949 124±5* (n=8)
IGF-I + R59949 89±6* (n=8)
NGF 159±12* (n=6)
NGF + IGF-I 106±3# (n=8)
NGF + IGF-I + R59949 154±7* (n=7)
C2- Cer 162±17* (n=6)
C2- Cer + IGF-I 118±10§ (n=6)
C2- Cer + IGF-I + R59949 155±11* (n=6)
Cer-1-P 81±5* (n=3)
Cer-1-P + NGF 143±13* (n=8)
Quiescent otic vesicles were dissected from HH18 chick embryos and
cultured for 16 hours with R59949 (1 µM), IGF-I (1 nM), NGF (4 nM), C2-
Cer (5 µM) or Cer-1-P (25 µM). A pretreatment of 30 minutes was done in
those conditions where R59949 was used. Quantification of nucleosomes was
made in single otic vesicle explants and normalized versus control value taken
as 100. n is the total number of explants tested in at least three different
experiments. Values are presented as mean±s.e.m. Statistical significance
estimated by ANOVA was as follows: * P<0.005 versus control, #P<0.005
versus NGF and §P<0.05 versus C2-Cer.
NGF IGF-I
p75NTR
a NGF
DNA fragmentation
Apoptosis
PARP cleavage
Caspases activation
Cer - 1- P
Akt phosphorylation
Survival
PCNA increase
Ceramide
increasezVAD
DEVD
zVAD
R59949
a p75NTR
Fig. 6. NGF signalling through p75 in the otic vesicle. A
proposed scheme showing the intracellular signalling pathways
activated by NGF and IGF-I and how they balance cell death.
Arrows denote facilitating action whereas crossbars indicate
inhibitory influence. 
485Cell death and survival in the otic vesicle
ceramide in ultraviolet light-induced apoptosis. Mol. Cell Biochem. 219, 21-
27.
Chinnaiyan, A. M., Tepper, C. G., Seldin, M. F., O’Rourke, K., Kischkel,
F. C., Hellbardt, S., Krammer, P., Peter, M. and Dixit, V. M. (1996).
FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor
necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271, 4961-4965.
Cho, H., Thorvaldsen, J. L., Chu, Q., Feng, F. and Birnbaum, M. J. (2001).
Akt1/PKB a is required for normal growth but dispensable for maintenance
of glucose homeostasis in mice. J. Biol. Chem. 276, 38349-38352.
Chrysis, D., Calikoglu, A. S., Ye, P. and D’Ercole, A. J. (2001). Insulin-like
growth factor-I overexpression attenuates cerebellar apoptosis by altering
the expresión of Bcl family proteins in a developmentally specific manner.
J. Neurosci. 21, 1481-1489.
Craighead, M., Pole, J. and Waters, C. (2000). Caspases mediate C2-
ceramide-induced apoptosis of the human oligodendroglial cell line,
MO3.13. Neurosci. Lett. 278, 125-128.
Cutler, R. G. and Mattson, M. P. (2001). Sphingomyelin and ceramide as
regulators of development and lifespan. Mech. Ageing Dev. 122, 895-908.
de la Rosa, E. J. and de Pablo, F. (2000). Cell death in early neural
development: beyond the neurotrophic theory. Trends Neurosci. 23, 454-
458.
Diaz, B., Pimentel, B., de Pablo, F. and de la Rosa, E. J. (1999). Apoptotic
cell death of proliferating neuroepithelial cells in the embryonic retina is
prevented by insulin. Eur. J. Neurosci. 11, 1624-1632.
D’Mello, S. R. (1998). Molecular regulation of neuronal apoptosis. Curr. Top.
Dev. Biol. 39, 187-213. 
Dobrowsky, R. T. and Carter, B. D. (2000). p75 neurotrophin receptor
signalling: mechanisms for neurotrophic modulation of cell stress? J.
Neurosci. Res. 61, 237-243.
Dobrowsky, R. T., Werner, M. H., Castellino, A. M., Chao, M. V. and
Hannun, Y. A. (1994). Activation of the sphingomyelin cycle through the
low affinity neurotrophin receptor. Science 265, 1596-1599.
Dobrowsky, R. T., Jenkins, G. M. and Hannun, Y. A. (1995). Neurotrophins
induce sphingomyelin hydrolysis. J. Biol. Chem. 270, 22135-22142.
Dressler, K. A. and Kolesnick, R. N. (1990). Ceramide-1-Phosphate, a novel
phospholipid in human leukaemia (HL-60) cells. J. Biol. Chem. 265, 14917-
14921.
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper,
G. M., Segal, R. A., Kaplan, D. R. and Greenberg, M. E. (1997).
Regulation of neuronal survival by the serine-threonine protein kinase Akt.
Science 275, 661-665.
Fekete, D. M., Hamburger, S. A., Waring, M. T., Riedl, A. E. and García,
L. F. (1997). Involvement of programmed cell death in morphogenesis of
the vertebrate inner ear. Development 124, 2451-2461.
Frade, J. M. (2000). Unschedule re-entry into the cell cycle induced by
NGF precedes cell death in nascent retinal neurones. J. Cell Sci. 113,
1139-1148.
Frade, J. M. and Barde, Y. A. (1998). Nerve growth factor: two receptors,
multiple functions. BioEssays 20, 137-145.
Frade, J. M., Rodríguez-Tebar, A. and Barde, Y. A. (1996). Induction of
cell death by endogenous nerve growth factor through p75. Nature 383, 166-
168.
Frago, L. M., León, Y., de la Rosa, E. J., Gómez-Muñoz, A. and Varela-
Nieto, I. (1998). Nerve growth factor and ceramides modulate cell death in
the early developing inner ear. J. Cell Sci. 111, 549-556.
Frago, L. M., Camarero, G., Cañón, S., Pañeda, C., Sanz, C., León, Y.,
Giráldez, F. and Varela-Nieto, I. (2000). Role of diffusible and
transcription factors in inner ear development: implications in regeneration.
Histol. Histopathol. 15, 657-666. 
Glücksmann, A. (1951). Cell death in normal vertebrate ontogeny. Biol. Rev.
26, 59-86.
Gómez del Pulgar, T., Velasco, G., Sánchez, C., Haro, A. and Guzmán, M.
(2002). De novo-synthesized ceramide is involved in cannabinoid-induced
apoptosis. Biochem. J. 363, 183-188.
González-Hoyuela, M., Barbas, J. A. and Rodríguez-Tébar, A. (2001). The
autoregulation of retinal ganglion cell number. Development 128, 117-124.
Grullich, C., Sullards, M. C., Fuks, Z., Merrill, A. H. and Kolesnick, R.
(2000). CD95(Fas/APO-1) signals ceramide generation independent of the
effector stage of apoptosis. J. Biol. Chem. 275, 8650-8656.
Gu, C., Cassaccia-Bonnefil, P., Srinivasan, A. and Chao, M. V. (1999).
Oligodendrocyte apoptosis mediated by caspase activation. J. Neurosci. 19,
3043-3049.
Hallbook, F., Ayer-Lelievre, C., Ebendal, T. and Persson, H. (1990).
Expression of nerve growth factor receptor mRNA during early development
of the chicken embryo: emphasis on cranial ganglia. Development 108, 693-
704.
Hamburger, V. and Hamilton, H. L. (1951). A series of normal stages in the
development of the chick embryo. J. Morphol. 88, 49-92.
Hartfield, P. J., Bilney, A. J. and Murray, A. W. (1998). Neurotrophic factors
prevent ceramide-induced apoptosis downstream of c-Jun N-terminal kinase
activation in PC-12 cells. J. Neurochem. 71, 161-169.
Hemond, S. G. and Morest, D. K. (1991). Ganglion formation from the otic
placode and the otic crest in the chick embryo: mitosis, migration, and the
basal lamina. Anat. Embryol. 184, 1-13.
Herget, T., Esdar, C., Oehrlein, S. A., Heinrich, M., Schütze, S., Maelicke,
A. and van Echten-Deckert, G. (2000). Production of ceramides causes
apoptosis during early neural differentiation in vitro. J. Biol. Chem. 275,
30344-30354.
Huber, L. J. and Chao, M. V. (1995). Mesenchymal and neuronal cell
expression of the p75 neurotrophin receptor gene occur by different
mechanisms. Dev. Biol. 167, 227-238.
Jacobson, M. D., Weil, M. and Raff, M. C. (1997). Programmed cell death
in animal development. Cell 88, 347-354.
Jiang, Y., Sakane, F., Kanoh, H. and Walsh, J. P. (2000). Selectivity of the
diacylglycerol kinase inhibitor 3-[2-(4-[bis-(4-fluorophenyl)methylene]-1-
piperidinyl)ethyl]-2,3-dihydro-2-thioxo-4(1H) quinazolinone (R59949)
among diacylglycerol kinase subtypes. Biochem. Pharmacol. 59, 763-772.
Kaplan, D. R. and Miller, F. D. (2000). Neurotrophin signal transduction in
the nervous system. Curr. Opin. Neurobiol. 10, 381-391.
Kishikawa, K., Chalfant, C. E., Perry, D. K., Bielawska, A. and Hannun,
Y. A. (1999). Phosphatidic acid is a potent and selective inhibitor of protein
phosphatase 1 and an inhibitor of ceramide-mediated responses. J. Biol.
Chem. 274, 21335-21341.
Klesse, L. J. and Parada, L. F. (1999). Trks: Signal transduction and
intracellular pathways. Microsc. Res Tech. 45, 210-215.
Large, T. H., Weskamp, G., Helder, J. C., Radeke, M. J., Misko, T. P.,
Shooter, E. M. and Reichardt, L. F. (1989). Structure and developmental
expression of the Nerve Growth Factor receptor in the chicken central
nervous system. Neuron 2, 1123-1134
Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G. and
Earnshaw, W. C. (1994). Cleavage of poly(ADP-ribose)polymerase by a
proteinase with properties like ICE. Nature 371, 346-347.
Lee, F. S., Kim, A. H., Khursigara, G. and Chao, M. V. (2001). The
uniqueness of being a neurotrophin receptor. Curr. Opin. Neurobiol. 11, 281-
286.
León, Y., Sanz, C., Giráldez, F. and Varela-Nieto, I. (1998). Induction of
cell growth by insulin and insulin-like growth factor-I is associated with Jun
expression in the otic vesicle. J. Comp. Neurol. 398, 323-332.
León, Y., Sanz, C., Frago, L. M., Camarero, G., Cañón, S., Varela-Nieto,
I. and Giráldez, F. (1999). Involvement of Insulin-like growth factor-I
in inner ear organogenesis and regeneration. Horm. Metab. Res. 31,
126-132.
Liepinsh, E., Ilag, L. L., Otting, G. and Ibáñez, C. F. (1997). NMR structure
of the death domain of the p75. EMBO J. 16, 4999-5005.
Lievremont, J. P., Sciorati, C., Morandi, E., Paolucci, C., Bunone, G., de
lla Valle, G., Meldolesi, J. and Clementi, E. (1999). The p75(NTR)-
induced apoptotic program develops through a ceramide-caspase pathway
negatively regulated by nitric oxide. J. Biol. Chem. 274, 15466-15472.
Mizushima, N., Koike, R., Kohsaka, H., Kushi, Y., Handa, S., Yagita, H.
and Miyasaka, N. (1996). Ceramide induces apoptosis via CPP32
activation. FEBS Lett. 395, 267-271.
Mochizuki, T., Asai, A., Saito, N., Tanaka, S., Katagiri, H., Asano, T.,
Nakane, M., Tamura, A., Kuchini, Y., Kitanaka, C. and Kirino, T.
(2002). Akt protein kinase inhibits non-apoptotic programmed cell death
induced by ceramide. J. Biol. Chem. 277, 2790-2797.
Morita, Y., Perez, G. I., Paris, F., Miranda, S. R., Ehleiter, D., Haimovitz-
Friedman, A., Fuks, Z., Xie, Z., Reed, J. C., Schuchman, E. H. et al.
(2000). Oocyte apoptosis is suppressed by disruption of the acid
sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat. Med.
6, 1109-1114.
Oppenheim, R. M., Flavell, R. A., Vinsant, S., Prevette, D., Kuan, C. Y.
and Rakic, P. (2001). Programmed cell death of developing mammalian
neurons after genetic deletion of caspases. J. Neurosci. 21, 4752-4760.
Paradis, S. and Ruvkun, G. (1998). Caenorhabditis elegans Akt/PKB
transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-
16 transcription factor. Genes Dev. 12, 2488-2498.
Peña, L.A., Fuks, Z. and Kolesnick, R. (1997). Stress-induced apoptosis and
the sphingomyelin pathway. Biochem. Pharmacol. 53, 615-621.
486
Raff, M. C. (1992). Social controls on cell survival and cell death. Nature 356,
397-400.
Raff, M. C., Barres, B. A., Burne, J. F., Coles, H. S., Ishizaki, Y. and
Jacobson, M. D. (1993). Programmed cell death and the control of cell
survival: lessons from the nervous system. Science 262, 695-700. 
Roux, P. P., Bhakar, A. L., Kennedy, T. E. and Barker, P. A. (2001). The
p75 neurotrophin receptor activates Akt (Protein Kinase B) through a
phosphatidylinositol 3-kinase-dependent pathway. J. Biol. Chem. 276,
23097-23104.
Sanz, C., León, Y., Cañón, S., Alvarez, L., Giráldez, F. and Varela-Nieto,
I. (1999a). Pattern of expression of the Jun family of transcription factors
during the early development of the inner ear: implications in apoptosis. J.
Cell Sci. 112, 3967-3974.
Sanz, C., León, Y., Troppmair, J., Rapp, U. R. and Varela-Nieto, I. (1999b).
Strict regulation of c-Raf kinase levels is required for early organogenesis
of the vertebrate inner ear. Oncogene 18, 429-437.
Schecterson, L. C. and Bothwell, M. (1994). Neurotrophin and
neurotrophin receptor mRNA expression in developing inner ear. Hearing
Res. 73, 92-100.
Schneider, E. G. and Kennedy, E. P. (1973). Phosphorylation of ceramide by
diglyceride kinase preparations from Escherichia coli. J. Biol. Chem. 248,
3739-3741.
Schubert, K. M., Scheid, M. P. and Duronio, V. (2000). Ceramide inhibits
protein kinase B/Akt by promoting dephosphorylation of serine 473. J. Biol.
Chem. 275, 13330-13335.
Sugiura, M., Kono, K., Liu, H., Shimizugawa, T., Minekura, H., Spiegel,
S. and Kohama, T. (2002). Ceramide kinase, a novel lipid kinase.
Molecular cloning and functional characterization. J. Biol. Chem. 277,
23294-23300.
Sweeney, E. A., Inokuchi, J. and Igarashi, Y. (1998). Inhibition of
sphingolipid induced apoptosis by caspase inhibitors indicates that
sphingosine acts in an earlier part of the apoptotic pathway than ceramide.
FEBS Lett. 425, 61-65.
Teruel, T., Hernandez, R. and Lorenzo, M. (2001). Ceramide mediates
insulin resistance by tumor necrosis factor-a in brown adipocytes by
maintaining Akt in an inactive dephosphorylated state. Diabetes 50, 2563-
2571.
Torres, M. and Giraldez, F. (1998). The development of the vertebrate inner
ear. Mech. Dev. 71, 5-21.
Vaux, D. L. and Korsmeyer, S. J. (1999). Cell death in development. Cell 22,
245-254.
Verdu, J., Buratovich, M. A., Wilder, E. L. and Birnbaum, M. J. (1999).
Cell-autonomous regulation of cell and organ growth in Drosophila by
Akt/PKB. Nat. Cell. Biol. 1, 500-506.
von Bartheld, C. S., Patterson, S. L., Heuer, J. G., Wheeler, E. F., Bothwell,
M. and Rubel, E. W. (1991). Expression of nerve growth factor receptors
in the developing inner ear of chick and rat. Development 113, 455-470.
von Schack, D., Casademunt, E., Schweigreiter, R., Meyer, M., Bibel, M.
and Dechant, G. (2001). Complete ablation of the neurotrophin receptor
p75NTR causes defects both in the nervous and the vascular system. Nat.
Neurosci. 4, 977-978.
Wilkinson, D. G. (1992). Whole mount in situ hybridisation of vertebrate
embryos. In In situ hybridisation, pp. 75-83. Oxford: IRL press.
Woods, K., Camacho-Hubner, C., Savage, M. and Clark, A. (1996).
Intrauterine growth retardation and postnatal growth failure associated with
deletion of the insulin-like growth factor I gene. N. Engl. J. Med. 335, 1363-
1367.
Woods, K. A., Camacho-Hubner, C., Barter, D., Clark, A. J. and Savage, M.
O. (1997). Insulin-like growth factor I gene deletion causing intrauterine
growth retardation and severe short stature. Acta Paediatr. Suppl. 423, 39-45.
Wu, D. K. and Oh, S. H. (1996). Sensory organ generation in the chick inner
ear. J. Neurosci. 16, 6454-6462.
Yoon, S. O., Casaccia-Bonnefil, P., Carter, B. and Chao, M. V. (1998).
Competitive signaling between trkA and p75 nerve growth factor receptors
determines cell survival. J. Neurosci. 18, 3273-3281.
Zheng, W. H., Kar, S., Dore, S. and Quirion, R. (2000). Insulin-like growth
factor-1 (IGF-I): a neuroprotective trophic factor acting via the Akt kinase
pathway. J. Neural. Transm. Suppl. 60, 261-272.
Zundel, W. and Giaccia, A. (1998). Inhibition of the anti-apoptotic
PI(3)K/Akt/Bad pathway by stress. Genes Dev. 12, 1941-1946.
Journal of Cell Science 116 (3)
